<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04400942</url>
  </required_header>
  <id_info>
    <org_study_id>NOM-MYOMA RES</org_study_id>
    <nct_id>NCT04400942</nct_id>
  </id_info>
  <brief_title>Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy</brief_title>
  <official_title>A Retrospective Study for Developing a Nomogram for Predicting Change of Complete Myoma Resection During Hysteroscopic Myomectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale Policlinico San Martino</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale Policlinico San Martino</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this observational retrospective analysis is to evaluate predictive factors for
      complete myoma resection during hysteroscopic myomectomy for developing and validating a
      nomogram.

      This tool can help clinicians to support the patient in making an informed decision about
      therapeutic options for uterine submucous myomas by defining risk factors predicting a high
      complexity myomectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overall, 10% of all uterine myomas are submucosal. These myomas spread into the uterine
      cavity, lifting the endometrial mucosa, and are a common cause of abnormal uterine bleeding,
      dysmenorrhea, early miscarriage and they may be a cause of infertility.

      Hysteroscopic myomectomy is the surgical procedure of choice for the treatment of submucosal
      myomas, because it is minimally invasive and has the advantage of preserving the integrity of
      the uterine wall.

      The characteristics of the myomas (size, number and location) enables the surgeon to choose
      the surgical approach that will provide the best outcome for the patient, and may predict the
      chances of a complete hysteroscopic resection of myomas in one procedure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with complete resection of myomas</measure>
    <time_frame>At the end of the hysteroscopic procedure</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Uterine Fibroids</condition>
  <condition>Uterine Myomas</condition>
  <arm_group>
    <arm_group_label>Women with uterine myomas undergoing hysteroscopic myomectomy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Transvaginal ultrasound</intervention_name>
    <description>Transvaginal ultrasonographic scan aims to evaluate number, size (diameter and volume), location and appearance of submucous uterine myomas, concomitant presence of adenomyosis</description>
    <arm_group_label>Women with uterine myomas undergoing hysteroscopic myomectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Anamnesis</intervention_name>
    <description>Anamnesis aims to collect data about age, BMI, previous hormonal therapies (such as ulipristal acetate or gonadotropin-releasing hormone agonists) with submucous uterine myomas</description>
    <arm_group_label>Women with uterine myomas undergoing hysteroscopic myomectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Operative hysteroscopy</intervention_name>
    <description>Operative hysteroscopy allows a direct evaluation of number, size (diameter and volume), location and appearance of submucous uterine myomas. This exam allows the resection of the myomas.</description>
    <arm_group_label>Women with uterine myomas undergoing hysteroscopic myomectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with trasonographic diagnosis of uterine myomas undergoing hysteroscopic
        myomectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with ultrasonographic diagnosis of uterine myomas

        Exclusion Criteria:

          -  patients with previous incomplete hysteroscopic myoma resection;

          -  patients undergoing additional surgical procedures performed by hysteroscopy (such as,
             resection of endometrial polyps);

          -  patients undergoing associated non-hysteroscopic surgical procedures;

          -  patients with severe cardiovascular disease, decompensated diabetes and severe
             hematologic disorders
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Simone Ferrero, MD, PhD</last_name>
    <phone>0039010511525</phone>
    <email>simone.ferrero@unige.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>IRCCS Ospedale Policlinico San Martino</name>
      <address>
        <city>Genoa</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simone Ferrero</last_name>
      <phone>+39 010 511525</phone>
      <email>simone.ferrero@unige.it</email>
    </contact>
    <investigator>
      <last_name>Fabio Barra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Vargas MV, Moawad GN, Sievers C, Opoku-Anane J, Marfori CQ, Tyan P, Robinson JK. Feasibility, Safety, and Prediction of Complications for Minimally Invasive Myomectomy in Women With Large and Numerous Myomata. J Minim Invasive Gynecol. 2017 Feb;24(2):315-322. doi: 10.1016/j.jmig.2016.11.014. Epub 2016 Dec 7.</citation>
    <PMID>27939896</PMID>
  </reference>
  <reference>
    <citation>Ferrero S, Tafi E, Racca A, Leone R, Maggiore U, Remorgida V, Venturini PL. Ulipristal Acetate Prior to High Complexity Hysteroscopic Myomectomy: Prospective Study. J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S181. doi: 10.1016/j.jmig.2015.08.666. Epub 2015 Oct 15.</citation>
    <PMID>27678974</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 19, 2020</study_first_submitted>
  <study_first_submitted_qc>May 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 26, 2020</study_first_posted>
  <last_update_submitted>July 26, 2020</last_update_submitted>
  <last_update_submitted_qc>July 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale Policlinico San Martino</investigator_affiliation>
    <investigator_full_name>Fabio Barra</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
    <mesh_term>Myoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

